Second Lung Lobectomies: Are they Safe and Feasible?

Ordóñez Lozano, P.A. ; Royo Crespo, I. ; Muñoz-González, N. ; Embún Flor, R. (Universidad de Zaragoza)

Resumen: Dear Editor,

The diagnosis of multiple primary lung cancers (MPLC) accounts for approximately 0.2%–20% of all cases of lung cancer.1 The 2 presentations of MPLC, synchronous and metachronous, can manifest in 2 ways: either as a metastatic lesion of a primary lung tumor, or as multiple, unrelated lesions that can be defined as primary disease. The term MPLC is used to refer to the latter case, in which 2 or more primary malignant tumors are unrelated to each other, but present simultaneously or successively in the lung.2 Second lung lobectomies are very rarely described in the literature. The aim of this study was to determine postoperative morbidity and mortality in patients undergoing a second lung lobectomy. This is a descriptive study of postoperative morbidity and mortality (during hospitalization or in the first 30 days post-surgery) in a series of patients undergoing a second lung lobectomy between January 1, 2009 and December 31, 2014. Second lobectomies conducted to complete a pneumonectomy were not included in the analysis...

Idioma: Inglés

DOI: 10.1016/j.arbr.2018.02.006

Año: 2018

Publicado en: Archivos de Bronconeumologia 54, 4 (2018), 227-228
ISSN: 0300-2896

Factor impacto JCR: 4.214 (2018)

Categ. JCR: RESPIRATORY SYSTEM rank: 15 / 62 = 0.242 (2018) - Q1 - T1

Factor impacto SCIMAGO: 0.396 - Pulmonary and Respiratory Medicine (Q3)

Tipo y forma: (Versión definitiva)

Área (Departamento): Área Cirugía (Dpto. Cirugía,Ginecol.Obstetr.)